nodes	percent_of_prediction	percent_of_DWPC	metapath
Flurazepam—ABCB1—Lisinopril—dilated cardiomyopathy	0.0696	0.532	CbGbCtD
Flurazepam—ABCB1—Spironolactone—dilated cardiomyopathy	0.0613	0.468	CbGbCtD
Flurazepam—Lethargy—Spironolactone—dilated cardiomyopathy	0.0199	0.0353	CcSEcCtD
Flurazepam—Ataxia—Spironolactone—dilated cardiomyopathy	0.0183	0.0325	CcSEcCtD
Flurazepam—Heartburn—Lisinopril—dilated cardiomyopathy	0.0159	0.0283	CcSEcCtD
Flurazepam—Drowsiness—Spironolactone—dilated cardiomyopathy	0.015	0.0267	CcSEcCtD
Flurazepam—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.014	0.0249	CcSEcCtD
Flurazepam—Lightheadedness—Furosemide—dilated cardiomyopathy	0.0131	0.0232	CcSEcCtD
Flurazepam—Mental disability—Furosemide—dilated cardiomyopathy	0.0127	0.0225	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.0109	0.0194	CcSEcCtD
Flurazepam—Lethargy—Furosemide—dilated cardiomyopathy	0.0108	0.0192	CcSEcCtD
Flurazepam—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.0106	0.0189	CcSEcCtD
Flurazepam—Leukopenia—Spironolactone—dilated cardiomyopathy	0.0105	0.0186	CcSEcCtD
Flurazepam—Irritability—Furosemide—dilated cardiomyopathy	0.0101	0.018	CcSEcCtD
Flurazepam—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00979	0.0174	CcSEcCtD
Flurazepam—Confusional state—Spironolactone—dilated cardiomyopathy	0.00964	0.0171	CcSEcCtD
Flurazepam—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00957	0.017	CcSEcCtD
Flurazepam—Somnolence—Spironolactone—dilated cardiomyopathy	0.0085	0.0151	CcSEcCtD
Flurazepam—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00821	0.0146	CcSEcCtD
Flurazepam—Drowsiness—Furosemide—dilated cardiomyopathy	0.00816	0.0145	CcSEcCtD
Flurazepam—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00788	0.014	CcSEcCtD
Flurazepam—Sweating—Furosemide—dilated cardiomyopathy	0.00782	0.0139	CcSEcCtD
Flurazepam—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00761	0.0135	CcSEcCtD
Flurazepam—Irritability—Lisinopril—dilated cardiomyopathy	0.00758	0.0135	CcSEcCtD
Flurazepam—Ataxia—Lisinopril—dilated cardiomyopathy	0.00747	0.0133	CcSEcCtD
Flurazepam—Pruritus—Spironolactone—dilated cardiomyopathy	0.00677	0.012	CcSEcCtD
Flurazepam—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00654	0.0116	CcSEcCtD
Flurazepam—Dizziness—Spironolactone—dilated cardiomyopathy	0.00633	0.0112	CcSEcCtD
Flurazepam—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00624	0.0111	CcSEcCtD
Flurazepam—Vomiting—Spironolactone—dilated cardiomyopathy	0.00608	0.0108	CcSEcCtD
Flurazepam—Rash—Spironolactone—dilated cardiomyopathy	0.00603	0.0107	CcSEcCtD
Flurazepam—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00603	0.0107	CcSEcCtD
Flurazepam—Vision blurred—Furosemide—dilated cardiomyopathy	0.00601	0.0107	CcSEcCtD
Flurazepam—Headache—Spironolactone—dilated cardiomyopathy	0.00599	0.0107	CcSEcCtD
Flurazepam—Sweating—Lisinopril—dilated cardiomyopathy	0.00587	0.0104	CcSEcCtD
Flurazepam—Agitation—Furosemide—dilated cardiomyopathy	0.00586	0.0104	CcSEcCtD
Flurazepam—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00571	0.0102	CcSEcCtD
Flurazepam—Leukopenia—Furosemide—dilated cardiomyopathy	0.00571	0.0101	CcSEcCtD
Flurazepam—Nausea—Spironolactone—dilated cardiomyopathy	0.00568	0.0101	CcSEcCtD
Flurazepam—Hallucination—Lisinopril—dilated cardiomyopathy	0.00547	0.00972	CcSEcCtD
Flurazepam—Dry mouth—Furosemide—dilated cardiomyopathy	0.00531	0.00944	CcSEcCtD
Flurazepam—Confusional state—Furosemide—dilated cardiomyopathy	0.00525	0.00933	CcSEcCtD
Flurazepam—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.0052	0.00925	CcSEcCtD
Flurazepam—Shock—Furosemide—dilated cardiomyopathy	0.00512	0.0091	CcSEcCtD
Flurazepam—Flushing—Lisinopril—dilated cardiomyopathy	0.0051	0.00907	CcSEcCtD
Flurazepam—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00503	0.00894	CcSEcCtD
Flurazepam—Anorexia—Furosemide—dilated cardiomyopathy	0.00496	0.00882	CcSEcCtD
Flurazepam—Hypotension—Furosemide—dilated cardiomyopathy	0.00486	0.00864	CcSEcCtD
Flurazepam—Tension—Lisinopril—dilated cardiomyopathy	0.00469	0.00835	CcSEcCtD
Flurazepam—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00469	0.00833	CcSEcCtD
Flurazepam—Nervousness—Lisinopril—dilated cardiomyopathy	0.00465	0.00826	CcSEcCtD
Flurazepam—Somnolence—Furosemide—dilated cardiomyopathy	0.00463	0.00822	CcSEcCtD
Flurazepam—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00452	0.00804	CcSEcCtD
Flurazepam—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00451	0.00802	CcSEcCtD
Flurazepam—Constipation—Furosemide—dilated cardiomyopathy	0.00445	0.00791	CcSEcCtD
Flurazepam—Syncope—Lisinopril—dilated cardiomyopathy	0.00429	0.00763	CcSEcCtD
Flurazepam—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00429	0.00762	CcSEcCtD
Flurazepam—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00428	0.00761	CcSEcCtD
Flurazepam—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00426	0.00756	CcSEcCtD
Flurazepam—Palpitations—Lisinopril—dilated cardiomyopathy	0.00423	0.00752	CcSEcCtD
Flurazepam—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00421	0.00747	CcSEcCtD
Flurazepam—Chest pain—Lisinopril—dilated cardiomyopathy	0.00407	0.00724	CcSEcCtD
Flurazepam—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00407	0.00724	CcSEcCtD
Flurazepam—Anxiety—Lisinopril—dilated cardiomyopathy	0.00406	0.00722	CcSEcCtD
Flurazepam—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00398	0.00708	CcSEcCtD
Flurazepam—Confusional state—Lisinopril—dilated cardiomyopathy	0.00394	0.007	CcSEcCtD
Flurazepam—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.0039	0.00694	CcSEcCtD
Flurazepam—Shock—Lisinopril—dilated cardiomyopathy	0.00384	0.00683	CcSEcCtD
Flurazepam—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00377	0.00671	CcSEcCtD
Flurazepam—Asthenia—Furosemide—dilated cardiomyopathy	0.00373	0.00664	CcSEcCtD
Flurazepam—Anorexia—Lisinopril—dilated cardiomyopathy	0.00372	0.00662	CcSEcCtD
Flurazepam—Pruritus—Furosemide—dilated cardiomyopathy	0.00368	0.00654	CcSEcCtD
Flurazepam—Hypotension—Lisinopril—dilated cardiomyopathy	0.00365	0.00649	CcSEcCtD
Flurazepam—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00356	0.00633	CcSEcCtD
Flurazepam—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00356	0.00632	CcSEcCtD
Flurazepam—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00348	0.00619	CcSEcCtD
Flurazepam—Somnolence—Lisinopril—dilated cardiomyopathy	0.00347	0.00617	CcSEcCtD
Flurazepam—Dizziness—Furosemide—dilated cardiomyopathy	0.00344	0.00612	CcSEcCtD
Flurazepam—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00344	0.00611	CcSEcCtD
Flurazepam—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00339	0.00603	CcSEcCtD
Flurazepam—Constipation—Lisinopril—dilated cardiomyopathy	0.00334	0.00594	CcSEcCtD
Flurazepam—Vomiting—Furosemide—dilated cardiomyopathy	0.00331	0.00588	CcSEcCtD
Flurazepam—Rash—Furosemide—dilated cardiomyopathy	0.00328	0.00583	CcSEcCtD
Flurazepam—Dermatitis—Furosemide—dilated cardiomyopathy	0.00328	0.00583	CcSEcCtD
Flurazepam—Headache—Furosemide—dilated cardiomyopathy	0.00326	0.0058	CcSEcCtD
Flurazepam—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00322	0.00572	CcSEcCtD
Flurazepam—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00319	0.00568	CcSEcCtD
Flurazepam—Nausea—Furosemide—dilated cardiomyopathy	0.00309	0.00549	CcSEcCtD
Flurazepam—Asthenia—Lisinopril—dilated cardiomyopathy	0.0028	0.00498	CcSEcCtD
Flurazepam—Pruritus—Lisinopril—dilated cardiomyopathy	0.00276	0.00491	CcSEcCtD
Flurazepam—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00267	0.00475	CcSEcCtD
Flurazepam—Dizziness—Lisinopril—dilated cardiomyopathy	0.00258	0.00459	CcSEcCtD
Flurazepam—Vomiting—Lisinopril—dilated cardiomyopathy	0.00248	0.00441	CcSEcCtD
Flurazepam—Rash—Lisinopril—dilated cardiomyopathy	0.00246	0.00438	CcSEcCtD
Flurazepam—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00246	0.00437	CcSEcCtD
Flurazepam—Headache—Lisinopril—dilated cardiomyopathy	0.00245	0.00435	CcSEcCtD
Flurazepam—Nausea—Lisinopril—dilated cardiomyopathy	0.00232	0.00412	CcSEcCtD
Flurazepam—GABRB2—Ion channel transport—PLN—dilated cardiomyopathy	0.0022	0.00722	CbGpPWpGaD
Flurazepam—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	0.0022	0.00721	CbGpPWpGaD
Flurazepam—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00216	0.00708	CbGpPWpGaD
Flurazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00214	0.00703	CbGpPWpGaD
Flurazepam—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	0.00214	0.00702	CbGpPWpGaD
Flurazepam—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00212	0.00696	CbGpPWpGaD
Flurazepam—GABRB3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00211	0.00692	CbGpPWpGaD
Flurazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00211	0.0069	CbGpPWpGaD
Flurazepam—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.0021	0.00689	CbGpPWpGaD
Flurazepam—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00207	0.00679	CbGpPWpGaD
Flurazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00207	0.00678	CbGpPWpGaD
Flurazepam—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.00207	0.00677	CbGpPWpGaD
Flurazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00206	0.00674	CbGpPWpGaD
Flurazepam—GABRB3—Ion channel transport—PLN—dilated cardiomyopathy	0.00205	0.00673	CbGpPWpGaD
Flurazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00202	0.00662	CbGpPWpGaD
Flurazepam—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	0.00202	0.00661	CbGpPWpGaD
Flurazepam—GABRR1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00201	0.00657	CbGpPWpGaD
Flurazepam—GABRG3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00197	0.00646	CbGpPWpGaD
Flurazepam—GABRB1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00194	0.00637	CbGpPWpGaD
Flurazepam—GABRR1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00192	0.0063	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00191	0.00627	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—ABCC9—dilated cardiomyopathy	0.00191	0.00627	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00187	0.00612	CbGpPWpGaD
Flurazepam—GABRA6—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00184	0.00602	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00183	0.00601	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—ACTN2—dilated cardiomyopathy	0.00183	0.00601	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00181	0.00595	CbGpPWpGaD
Flurazepam—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00181	0.00594	CbGpPWpGaD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00176	0.00578	CbGpPWpGaD
Flurazepam—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00176	0.00577	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00166	0.00544	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00161	0.00528	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00158	0.00519	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00158	0.00516	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00156	0.0051	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00155	0.00509	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00155	0.00507	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00152	0.00497	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00151	0.00495	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00149	0.00488	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00147	0.00481	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00145	0.00475	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00141	0.00461	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00139	0.00456	CbGpPWpGaD
Flurazepam—Chloroquine—TNF—dilated cardiomyopathy	0.00136	1	CrCbGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00133	0.00435	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00133	0.00435	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00129	0.00422	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00127	0.00417	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00127	0.00415	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00124	0.00408	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.00124	0.00405	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00124	0.00405	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00122	0.00399	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00121	0.00398	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00121	0.00398	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00119	0.00391	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00119	0.00391	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00118	0.00388	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00116	0.00381	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00116	0.0038	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00116	0.0038	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00114	0.00373	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00114	0.00373	CbGpPWpGaD
Flurazepam—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00111	0.00363	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00111	0.00363	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00111	0.00363	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00111	0.00363	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00111	0.00363	CbGpPWpGaD
Flurazepam—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.0011	0.00361	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00108	0.00353	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00106	0.00348	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00103	0.00337	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00103	0.00337	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00102	0.00333	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000973	0.00319	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000937	0.00307	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000933	0.00306	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000923	0.00302	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000911	0.00299	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000911	0.00299	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000898	0.00294	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000898	0.00294	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000873	0.00286	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000862	0.00283	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000849	0.00278	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000849	0.00278	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000847	0.00278	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000839	0.00275	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000839	0.00275	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000834	0.00274	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00079	0.00259	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000788	0.00258	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00078	0.00256	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000775	0.00254	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000767	0.00251	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000767	0.00251	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000766	0.00251	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000763	0.0025	CbGpPWpGaD
Flurazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00076	0.00249	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000752	0.00247	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000745	0.00244	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000745	0.00244	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000739	0.00242	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000734	0.00241	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000732	0.0024	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000732	0.0024	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000729	0.00239	CbGpPWpGaD
Flurazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000725	0.00237	CbGpPWpGaD
Flurazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000725	0.00237	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000721	0.00236	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000719	0.00236	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000719	0.00236	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000714	0.00234	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000714	0.00234	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000713	0.00234	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000702	0.0023	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000702	0.0023	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000693	0.00227	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.00069	0.00226	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00068	0.00223	CbGpPWpGaD
Flurazepam—GABRR1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000676	0.00222	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000669	0.00219	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000664	0.00218	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000652	0.00214	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000652	0.00214	CbGpPWpGaD
Flurazepam—GABRR2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000645	0.00211	CbGpPWpGaD
Flurazepam—GABRQ—Ion channel transport—RAF1—dilated cardiomyopathy	0.000645	0.00211	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000632	0.00207	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00063	0.00207	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000613	0.00201	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000613	0.00201	CbGpPWpGaD
Flurazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000597	0.00196	CbGpPWpGaD
Flurazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000588	0.00193	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000579	0.0019	CbGpPWpGaD
Flurazepam—GABRR1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000571	0.00187	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00057	0.00187	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000563	0.00185	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000563	0.00185	CbGpPWpGaD
Flurazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000556	0.00182	CbGpPWpGaD
Flurazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000549	0.0018	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000546	0.00179	CbGpPWpGaD
Flurazepam—GABRQ—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000545	0.00179	CbGpPWpGaD
Flurazepam—GABRR2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000545	0.00179	CbGpPWpGaD
Flurazepam—GABRG3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000531	0.00174	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000523	0.00172	CbGpPWpGaD
Flurazepam—GABRB1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000523	0.00171	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000508	0.00166	CbGpPWpGaD
Flurazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000502	0.00165	CbGpPWpGaD
Flurazepam—GABRA6—Ion channel transport—RAF1—dilated cardiomyopathy	0.000495	0.00162	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.00049	0.0016	CbGpPWpGaD
Flurazepam—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	0.000489	0.0016	CbGpPWpGaD
Flurazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000488	0.0016	CbGpPWpGaD
Flurazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000479	0.00157	CbGpPWpGaD
Flurazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000471	0.00154	CbGpPWpGaD
Flurazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000468	0.00153	CbGpPWpGaD
Flurazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000459	0.00151	CbGpPWpGaD
Flurazepam—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000457	0.0015	CbGpPWpGaD
Flurazepam—GABRG3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000449	0.00147	CbGpPWpGaD
Flurazepam—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000447	0.00146	CbGpPWpGaD
Flurazepam—GABRB1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000442	0.00145	CbGpPWpGaD
Flurazepam—GABRR1—Neuronal System—RAF1—dilated cardiomyopathy	0.000437	0.00143	CbGpPWpGaD
Flurazepam—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.000434	0.00142	CbGpPWpGaD
Flurazepam—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000426	0.0014	CbGpPWpGaD
Flurazepam—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000419	0.00137	CbGpPWpGaD
Flurazepam—GABRA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000418	0.00137	CbGpPWpGaD
Flurazepam—GABRR2—Neuronal System—RAF1—dilated cardiomyopathy	0.000417	0.00137	CbGpPWpGaD
Flurazepam—GABRQ—Neuronal System—RAF1—dilated cardiomyopathy	0.000417	0.00137	CbGpPWpGaD
Flurazepam—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000416	0.00136	CbGpPWpGaD
Flurazepam—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000413	0.00135	CbGpPWpGaD
Flurazepam—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000409	0.00134	CbGpPWpGaD
Flurazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000402	0.00132	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00038	0.00125	CbGpPWpGaD
Flurazepam—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000378	0.00124	CbGpPWpGaD
Flurazepam—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000367	0.0012	CbGpPWpGaD
Flurazepam—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00036	0.00118	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	0.000358	0.00117	CbGpPWpGaD
Flurazepam—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000357	0.00117	CbGpPWpGaD
Flurazepam—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000354	0.00116	CbGpPWpGaD
Flurazepam—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000352	0.00115	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000349	0.00114	CbGpPWpGaD
Flurazepam—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000345	0.00113	CbGpPWpGaD
Flurazepam—GABRG3—Neuronal System—RAF1—dilated cardiomyopathy	0.000344	0.00113	CbGpPWpGaD
Flurazepam—GABRB1—Neuronal System—RAF1—dilated cardiomyopathy	0.000339	0.00111	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—TAZ—dilated cardiomyopathy	0.000328	0.00108	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	0.000323	0.00106	CbGpPWpGaD
Flurazepam—GABRA6—Neuronal System—RAF1—dilated cardiomyopathy	0.00032	0.00105	CbGpPWpGaD
Flurazepam—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	0.000316	0.00104	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000316	0.00104	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000308	0.00101	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000308	0.00101	CbGpPWpGaD
Flurazepam—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000302	0.000989	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	0.000297	0.000973	CbGpPWpGaD
Flurazepam—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000289	0.000948	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000286	0.000937	CbGpPWpGaD
Flurazepam—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000281	0.000921	CbGpPWpGaD
Flurazepam—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000277	0.000908	CbGpPWpGaD
Flurazepam—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.000276	0.000905	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000276	0.000905	CbGpPWpGaD
Flurazepam—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000271	0.000889	CbGpPWpGaD
Flurazepam—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	0.000269	0.000883	CbGpPWpGaD
Flurazepam—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000265	0.000867	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	0.000259	0.00085	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000251	0.000821	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000242	0.000792	CbGpPWpGaD
Flurazepam—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00024	0.000788	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000237	0.000776	CbGpPWpGaD
Flurazepam—GABRR1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000235	0.000771	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	0.000235	0.000769	CbGpPWpGaD
Flurazepam—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000231	0.000758	CbGpPWpGaD
Flurazepam—GABRR2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000224	0.000735	CbGpPWpGaD
Flurazepam—GABRQ—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000224	0.000735	CbGpPWpGaD
Flurazepam—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	0.000212	0.000696	CbGpPWpGaD
Flurazepam—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000208	0.000681	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000208	0.000681	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000195	0.00064	CbGpPWpGaD
Flurazepam—GABRG3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000185	0.000606	CbGpPWpGaD
Flurazepam—GABRB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000182	0.000597	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.000177	0.000579	CbGpPWpGaD
Flurazepam—GABRA6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000172	0.000565	CbGpPWpGaD
Flurazepam—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00017	0.000557	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000157	0.000515	CbGpPWpGaD
Flurazepam—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000156	0.00051	CbGpPWpGaD
Flurazepam—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000151	0.000495	CbGpPWpGaD
Flurazepam—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000148	0.000486	CbGpPWpGaD
Flurazepam—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000146	0.000478	CbGpPWpGaD
Flurazepam—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000145	0.000475	CbGpPWpGaD
Flurazepam—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000142	0.000466	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000128	0.00042	CbGpPWpGaD
Flurazepam—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000124	0.000408	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.00012	0.000395	CbGpPWpGaD
Flurazepam—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000114	0.000374	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000109	0.000357	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000108	0.000353	CbGpPWpGaD
Flurazepam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000103	0.000336	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	8.79e-05	0.000288	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	8.56e-05	0.00028	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	8.07e-05	0.000264	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	7.86e-05	0.000257	CbGpPWpGaD
Flurazepam—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	7.7e-05	0.000253	CbGpPWpGaD
Flurazepam—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	7.07e-05	0.000232	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	6.37e-05	0.000209	CbGpPWpGaD
Flurazepam—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.24e-05	0.000204	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	6.21e-05	0.000203	CbGpPWpGaD
Flurazepam—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	5.59e-05	0.000183	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	4.8e-05	0.000157	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—CD36—dilated cardiomyopathy	4.67e-05	0.000153	CbGpPWpGaD
Flurazepam—ABCB1—Metabolism—AGT—dilated cardiomyopathy	4.21e-05	0.000138	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.96e-05	9.69e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.88e-05	9.44e-05	CbGpPWpGaD
Flurazepam—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.59e-05	8.5e-05	CbGpPWpGaD
